Hakan Alakus

3.7k total citations
113 papers, 2.3k citations indexed

About

Hakan Alakus is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Hakan Alakus has authored 113 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 62 papers in Surgery, 59 papers in Pulmonary and Respiratory Medicine and 35 papers in Oncology. Recurrent topics in Hakan Alakus's work include Gastric Cancer Management and Outcomes (38 papers), Esophageal Cancer Research and Treatment (37 papers) and Esophageal and GI Pathology (13 papers). Hakan Alakus is often cited by papers focused on Gastric Cancer Management and Outcomes (38 papers), Esophageal Cancer Research and Treatment (37 papers) and Esophageal and GI Pathology (13 papers). Hakan Alakus collaborates with scholars based in Germany, United States and Switzerland. Hakan Alakus's co-authors include Christiane J. Bruns, Arnulf H. Hölscher, Elfriede Bollschweiler, Seung‐Hun Chon, Alexander Quaas, Thomas Zander, Uta Drebber, Stefan Mönig, Heike Loeser and Ralf Metzger and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Bioinformatics.

In The Last Decade

Hakan Alakus

107 papers receiving 2.3k citations

Peers

Hakan Alakus
Hakan Alakus
Citations per year, relative to Hakan Alakus Hakan Alakus (= 1×) peers Florian Gebauer

Countries citing papers authored by Hakan Alakus

Since Specialization
Citations

This map shows the geographic impact of Hakan Alakus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hakan Alakus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hakan Alakus more than expected).

Fields of papers citing papers by Hakan Alakus

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hakan Alakus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hakan Alakus. The network helps show where Hakan Alakus may publish in the future.

Co-authorship network of co-authors of Hakan Alakus

This figure shows the co-authorship network connecting the top 25 collaborators of Hakan Alakus. A scholar is included among the top collaborators of Hakan Alakus based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hakan Alakus. Hakan Alakus is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Alakus, Hakan, Stefanie Brunner, Matthias Schmidt, et al.. (2024). Intraoperative thyroid frozen section: indications, results and consequences. Gland Surgery. 13(5). 630–639. 1 indexed citations
2.
Laible, Mark, Stefan Wöll, Özlem Türeci, et al.. (2023). The tight junction protein claudin 6 is a potential target for patient-individualized treatment in esophageal and gastric adenocarcinoma and is associated with poor prognosis. Journal of Translational Medicine. 21(1). 552–552. 17 indexed citations
3.
Fuchs, Hans F., et al.. (2023). Das hereditäre diffuse Magenkarzinom. Die Chirurgie. 94(5). 400–405.
4.
Quaas, Alexander, Dorothea Wagner, Marcel Verheij, et al.. (2022). Microsatellite instability and sex differences in resectable gastric cancer – A pooled analysis of three European cohorts. European Journal of Cancer. 173. 95–104. 15 indexed citations
6.
Quaas, Alexander, Sebastian Klein, Jennifer Quantius, et al.. (2021). Sex-specific prognostic effect of CD66b-positive tumor-infiltrating neutrophils (TANs) in gastric and esophageal adenocarcinoma. Gastric Cancer. 24(6). 1213–1226. 25 indexed citations
7.
Wu, Xiaolin, Jiahui Li, Asmae Gassa, et al.. (2020). Circulating tumor DNA as an emerging liquid biopsy biomarker for early diagnosis and therapeutic monitoring in hepatocellular carcinoma. International Journal of Biological Sciences. 16(9). 1551–1562. 105 indexed citations
8.
Plum, Patrick Sven, Heike Löser, Thomas Zander, et al.. (2020). GATA binding protein 6 (GATA6) is co-amplified with PIK3CA in patients with esophageal adenocarcinoma and is linked to neoadjuvant therapy. Journal of Cancer Research and Clinical Oncology. 147(4). 1031–1040. 5 indexed citations
9.
Loeser, Heike, Florian Gebauer, Christiane J. Bruns, et al.. (2020). Indoleamine 2,3‐Dioxygenase (IDO) Expression Is an Independent Prognostic Marker in Esophageal Adenocarcinoma. Journal of Immunology Research. 2020(1). 2862647–2862647. 10 indexed citations
10.
Schallenberg, Simon, Hakan Alakus, Reinhard Buettner, et al.. (2020). Loss of the SWI/SNF-ATPase subunit members SMARCF1 (ARID1A), SMARCA2 (BRM), SMARCA4 (BRG1) and SMARCB1 (INI1) in oesophageal adenocarcinoma. BMC Cancer. 20(1). 12–12. 41 indexed citations
11.
Plum, Patrick Sven, Florian Gebauer, Maxwell Kramer, et al.. (2019). HER2/neu (ERBB2) expression and gene amplification correlates with better survival in esophageal adenocarcinoma. BMC Cancer. 19(1). 38–38. 57 indexed citations
12.
Quaas, Alexander, Carina Heydt, Dirk Waldschmidt, et al.. (2019). Alterations in ERBB2 and BRCA and microsatellite instability as new personalized treatment options in small bowel carcinoma. BMC Gastroenterology. 19(1). 21–21. 7 indexed citations
13.
Kasper, Philipp, Isabelle Suárez, Norma Jung, et al.. (2018). Postoperative granulomatous peritonitis mimicking abdominal tuberculosis. Clinical Case Reports. 6(9). 1810–1814. 5 indexed citations
14.
Pasternack, Helen, Jana Fassunke, Patrick Sven Plum, et al.. (2018). Somatic alterations in circulating cell-free DNA of oesophageal carcinoma patients during primary staging are indicative for post-surgical tumour recurrence. Scientific Reports. 8(1). 14941–14941. 14 indexed citations
15.
Favi, Francesco, E. Bollschweiler, Felix Berlth, et al.. (2017). Neoadjuvant chemotherapy or chemoradiation for patients with advanced adenocarcinoma of the oesophagus? A propensity score-matched study. European Journal of Surgical Oncology. 43(8). 1572–1580. 22 indexed citations
16.
Alakus, Hakan, Shawn Yost, Brian Woo, et al.. (2015). BAP1 mutation is a frequent somatic event in peritoneal malignant mesothelioma. Journal of Translational Medicine. 13(1). 122–122. 51 indexed citations
17.
Fuchs, Hans F., Arnulf H. Hölscher, Jessica M. Leers, et al.. (2015). Long-term quality of life after surgery for adenocarcinoma of the esophagogastric junction: extended gastrectomy or transthoracic esophagectomy?. Gastric Cancer. 19(1). 312–317. 52 indexed citations
18.
Berlth, Felix, Stefan Mönig, Peter Grimminger, et al.. (2015). Both GLUT-1 and GLUT-14 are Independent Prognostic Factors in Gastric Adenocarcinoma. Annals of Surgical Oncology. 22(S3). 822–831. 30 indexed citations
19.
Maus, Martin, Peter Grimminger, Philip C. Mack, et al.. (2013). KRAS mutations in non-small-cell lung cancer and colorectal cancer: Implications for EGFR-targeted therapies. Lung Cancer. 83(2). 163–167. 31 indexed citations
20.
Alakus, Hakan, Ute Warnecke‐Eberz, Elfriede Bollschweiler, et al.. (2009). GNAS1 T393C polymorphism is associated with histopathological response to neoadjuvant radiochemotherapy in esophageal cancer. The Pharmacogenomics Journal. 9(3). 202–207. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026